04/29/2024 4:15 PM | Cyclacel Pharmaceuticals (Filer) Cyclacel Pharmaceuticals, Inc. (Filer)
| Form RW | |
04/26/2024 4:20 PM | Cyclacel Pharmaceuticals (Filer) Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/28/2024 4:23 PM | Cyclacel Pharmaceuticals (Filer) Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/25/2024 7:20 AM | Cyclacel Pharmaceuticals (Filer) Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
03/21/2024 4:00 PM | Cyclacel Pharmaceuticals (Filer) Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/13/2024 2:47 PM | Altium Capital Management LP (Filed by) Cyclacel Pharmaceuticals (Subject) Cyclacel Pharmaceuticals, Inc. (Subject)
| Form SC 13G/A | |
02/07/2024 4:03 PM | ACORN BIOVENTURES, L.P. (Filed by) Cyclacel Pharmaceuticals (Subject) Cyclacel Pharmaceuticals, Inc. (Subject)
| Form SC 13G/A | |
|
01/31/2024 3:56 PM | Cyclacel Pharmaceuticals (Issuer) Cyclacel Pharmaceuticals, Inc. (Issuer) SCHWARTZ BRIAN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 8:15 AM | Cyclacel Pharmaceuticals (Filer) Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/19/2024 3:58 PM | Cyclacel Pharmaceuticals (Filer) Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
01/12/2024 3:05 PM | Cyclacel Pharmaceuticals (Filer) Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2024 12:35 PM | Altium Capital Management LP (Filed by) Cyclacel Pharmaceuticals (Subject) Cyclacel Pharmaceuticals, Inc. (Subject)
| Form SC 13G | |
01/04/2024 3:05 PM | Cyclacel Pharmaceuticals (Filer) Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/26/2023 8:28 AM | Cyclacel Pharmaceuticals (Filer) Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 424B5 | |
12/26/2023 8:29 AM | Cyclacel Pharmaceuticals (Filer) Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/28/2023 8:20 PM | Cyclacel Pharmaceuticals (Filer) Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 10-K/A | |
11/28/2023 8:31 PM | Cyclacel Pharmaceuticals (Filer) Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
09/13/2023 11:15 PM | Cyclacel Pharmaceuticals (Filer) Cyclacel Pharmaceuticals, Inc. (Filer)
| Form EFFECT | |
09/01/2023 4:12 PM | Cyclacel Pharmaceuticals (Filer) Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
07/24/2023 3:02 PM | Cyclacel Pharmaceuticals (Filer) Cyclacel Pharmaceuticals, Inc. (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/07/2023 3:05 PM | Cyclacel Pharmaceuticals (Filer) Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/03/2023 3:55 PM | Cyclacel Pharmaceuticals (Issuer) Cyclacel Pharmaceuticals, Inc. (Issuer) HENNEY CHRISTOPHER S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 3:56 PM | Cyclacel Pharmaceuticals (Issuer) Cyclacel Pharmaceuticals, Inc. (Issuer) Ferguson Kenneth M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 3:56 PM | Cyclacel Pharmaceuticals (Issuer) Cyclacel Pharmaceuticals, Inc. (Issuer) Walker Karin L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 3:56 PM | Cyclacel Pharmaceuticals (Issuer) Cyclacel Pharmaceuticals, Inc. (Issuer) Kirschbaum Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 3:57 PM | Cyclacel Pharmaceuticals (Issuer) Cyclacel Pharmaceuticals, Inc. (Issuer) McBarron Paul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 3:57 PM | Cyclacel Pharmaceuticals (Issuer) Cyclacel Pharmaceuticals, Inc. (Issuer) Spiegel Robert J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 3:57 PM | BARKER SAM L (Reporting) Cyclacel Pharmaceuticals (Issuer) Cyclacel Pharmaceuticals, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 3:58 PM | Cyclacel Pharmaceuticals (Issuer) Cyclacel Pharmaceuticals, Inc. (Issuer) Rombotis Spiro George (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/11/2023 4:15 PM | Cyclacel Pharmaceuticals (Filer) Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023 3:06 PM | Cyclacel Pharmaceuticals (Filer) Cyclacel Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |